Sona Nanotech Inc (SONA) Price & Analysis

Compare

54 Followers

SONA Stock Chart & Stats

C$0.38

>-C$0.01(-2.00%)

At close: Jan 08 4:00 PM EST

C$0.38

>-C$0.01(-2.00%)

Day’s Range― - ―

52-Week RangeC$0.25 - C$0.91

Previous CloseN/A

Volume36.80K

Average Volume (3M)124.26K

Market Cap

C$43.51M

Enterprise ValueC$45.25M

Total Cash (Recent Filing)C$390.54K

Total Debt (Recent Filing)C$436.25K

Price to Earnings (P/E)―

Beta1.27

Next Earnings

Mar 02, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding113,005,360

10 Day Avg. Volume87,178

30 Day Avg. Volume124,263

Financial Highlights & Ratios

PEG Ratio1.33

Price to Book (P/B)10.82

Price to Sales (P/S)0.00

P/FCF Ratio-13.85

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.08

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Innovative Cancer TherapyThe promising preclinical results of Sona's Targeted Hyperthermia Therapy (THT) in cancer treatment could position the company as a leader in innovative therapies, enhancing its market position and long-term growth potential in the medical sector.

Strategic PresentationsPresenting at major conferences like the Canadian Melanoma Conference increases Sona's visibility and credibility in the medical community, potentially leading to new partnerships and market opportunities.

Stock Option GrantsThe allocation of stock options to directors and officers aligns management's interests with shareholders, potentially driving long-term strategic decisions that enhance shareholder value.

Bears Say

Zero RevenueThe absence of revenue generation poses a significant challenge to Sona's financial stability and limits its ability to invest in growth and innovation, potentially impacting its long-term viability.

Negative Cash FlowPersistent negative cash flow indicates reliance on external funding, which can be unsustainable and may hinder the company's ability to finance future projects or withstand economic downturns.

High LiabilitiesHigh liabilities and a poor debt-to-equity ratio suggest financial instability, which can limit Sona's operational flexibility and increase the risk of insolvency if not addressed.

Sona Nanotech Inc News

Sona Nanotech’s Innovative Approach to Metastatic Melanoma: A Study Update

Sona Nanotech, Inc (($TSE:SONA)) announced an update on their ongoing clinical study. Study Overview: Sona Nanotech Inc, in...

4M ago

SONA

Sona Nanotech’s Innovative Approach to Metastatic Melanoma: A Clinical Study Update

Sona Nanotech, Inc (($TSE:SONA)) announced an update on their ongoing clinical study. Sona Nanotech, Inc. is spearheading a...

4M ago

SONA

Sona Nanotech to Host Webinar on Innovative Cancer Therapy Clinical Study

Sona Nanotech Inc ( ($TSE:SONA) ) has shared an announcement. Sona Nanotech Inc. has announced an upcoming investor...

4M ago

Sona Nanotech Advances Clinical Trial for Innovative Cancer Therapy

Sona Nanotech Inc ( ($TSE:SONA) ) has shared an announcement. Sona Nanotech Inc. has provided an update on...

6M ago

Sona Nanotech Receives Ethics Approval for Melanoma Therapy Pilot Study

The latest update is out from Sona Nanotech Inc ( ($TSE:SONA) ). Sona Nanotech Inc. has received ethics...

7M ago

Sona Nanotech Initiates Feasibility Study for Innovative Cancer Therapy

Sona Nanotech Inc ( ($TSE:SONA) ) has issued an update. Sona Nanotech Inc. has commenced dosing in an...

8M ago

Sona Nanotech Receives Approval for Melanoma Clinical Trial

Sona Nanotech Inc ( ($TSE:SONA) ) has shared an announcement. Sona Nanotech Inc. has received ethics committee approval...

8M ago

Sona Nanotech Initiates Clinical Trial for Innovative Cancer Therapy

Sona Nanotech Inc ( ($TSE:SONA) ) has issued an announcement. Sona Nanotech Inc. has announced a clinical trial...

8M ago

Sona Nanotech Achieves Key Milestone with Successful FDA Toxicity Study

Sona Nanotech Inc ( ($TSE:SONA) ) has shared an update. Sona Nanotech Inc. announced successful completion of an...

9M ago

Sona Nanotech Advances Towards Clinical Trials with Successful Endotoxin Testing

Sona Nanotech Inc ( ($TSE:SONA) ) has provided an update. Sona Nanotech Inc. announced the successful completion of...

9M ago

SONA FAQ

What was Sona Nanotech Inc’s price range in the past 12 months?

Sona Nanotech Inc lowest stock price was C$0.24 and its highest was C$0.91 in the past 12 months.

What is Sona Nanotech Inc’s market cap?

Sona Nanotech Inc’s market cap is C$43.51M.

When is Sona Nanotech Inc’s upcoming earnings report date?

Sona Nanotech Inc’s upcoming earnings report date is Mar 02, 2026 which is in 12 days.

How were Sona Nanotech Inc’s earnings last quarter?

Sona Nanotech Inc released its earnings results on Sep 29, 2025. The company reported -C$0.01 earnings per share for the quarter, beating the consensus estimate of -C$0.014 by C$0.004.

Is Sona Nanotech Inc overvalued?

According to Wall Street analysts Sona Nanotech Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sona Nanotech Inc pay dividends?

Sona Nanotech Inc does not currently pay dividends.

What is Sona Nanotech Inc’s EPS estimate?

Sona Nanotech Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sona Nanotech Inc have?

Sona Nanotech Inc has 113,005,360 shares outstanding.

What happened to Sona Nanotech Inc’s price movement after its last earnings report?

Sona Nanotech Inc reported an EPS of -C$0.01 in its last earnings report, beating expectations of -C$0.014. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Sona Nanotech Inc?

Currently, no hedge funds are holding shares in TSE:SONA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Sona Nanotech Inc

Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company is based in Halifax, Canada.